Health Trials

Clinical trials

7

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease

Participants needed: 423
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Mar 13, 2026Locations: 32
Eligibility criteria

Voluntarily provide written informed consent [+6]

Known allergy or sensitivity to any study treatment (or any of its components) [+4]

Read more
Status: Not yet recruiting

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.

Participants needed: 123
Trial details
Phase: Phase 2Age: 18-58Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Feb 17, 2026
Eligibility criteria

Male or female 18 to 58 years of age, inclusive. [+3]

Women of childbearing potential or non-vasectomized males with partners of child... [+1]

Read more
Status: Not yet recruiting

A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism

This will be a multicenter, prospective, open label, non-randomized, single arm study evaluating the safety and effectiveness of the Technolas® TENEO 317 Model 2 (version 1.28 US software) Excimer Laser when used in LASIK surgery to treat myopia or myopic astigmatism. One or both eyes of a subject may be treated so long as both eyes meet all inclusion/exclusion requirements.

Participants needed: 32
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Jan 30, 2026
Eligibility criteria

Are 22 years of age or older. [+13]

Subjects for whom the combination of their baseline corneal thickness and the pl... [+22]

Read more
Status: Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.

Participants needed: 435
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Bausch & Lomb IncorporatedUpdated: Jan 12, 2026Locations: 14
Eligibility criteria

22 years of age or older, any race and any gender; [+6]

Pharmacologically dilated pupil size less than 7.0 mm in the IC-8 Apthera IOL ey... [+11]

Read more
Status: Not yet recruiting

Revive Toric RWE Study

This is a post-market observational clinical investigation. The objective of this observational study is to evaluate the visual performance and HCP satisfaction of REVIVE samfilcon B custom toric contact lenses.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Bausch & Lomb IncorporatedUpdated: Nov 28, 2025Locations: 3
Eligibility criteria

Be 18 years or older on the date the ICF is signed [+8]

Is participating in another research study [+4]

Read more
Status: Not yet recruiting

Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy

A Study to Investigate the Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia with or without Astigmatism by Transepithelial Photorefractive Keratectomy

Participants needed: 140
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Jun 15, 2025
Eligibility criteria

22 years of age or older at the time of the pre-operative examination. [+11]

Acute or chronic disease or illness that would increase operative risk or confou... [+14]

Read more
Status: Recruiting

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

Participants needed: 418
Trial details
Age: 8-12Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Jun 15, 2025Locations: 11
Eligibility criteria

Male or female aged 8 to 12 years plus 11 months old on the date the Informed As... [+8]

Subject has previously worn, or currently wears rigid gas permeable contact lens... [+16]

Read more